Impact of nevirapine or efavirenz coadministration and fosamprenavir daily regimen on ritonavir-boosted amprenavir pharmacokinetics in HIV infected patients

被引：0
|
作者：
Dailly, E.
Raffi, F.
Biron, C.
Allavena, C.
Jolliet, P.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
194
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Raffi, Francois
    Biron, Charlotte
    Allavena, C.
    Jolliet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (01) : 101 - 104
  • [2] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Tribut, Olivier
    Tattevin, Pierre
    Arvieux, Cedric
    Perre, Philippe
    Raffi, Francois
    Jolliet, Pascale
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 523 - 526
  • [3] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
  • [4] Amprenavir and lopinavir pharmacokinetics following coadministration of amprenavir or fosamprenavir with lopinavir/ritonavir, with or without efavirenz
    Pham, Paul A.
    Hendrix, Craig W.
    Barditch-Crovo, Patricia
    Parsons, Teresa
    Khan, Wasif
    Parish, Michelle
    Radebaugh, Christine
    Carson, Kathryn A.
    Pakes, Gary E.
    Qaqish, Roula
    Flexner, Charles
    ANTIVIRAL THERAPY, 2007, 12 (06) : 963 - 969
  • [5] Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients
    Dailly, Eric
    Allavena, Clotilde
    Bouquie, Regis
    Deslandes, Guillaume
    Raffi, Francois
    Jolliet, Pascale
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 42 - 46
  • [6] Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers
    Luber, A. D.
    Condoluci, D. V.
    Slowinski, P. D.
    Andrews, M.
    Olson, K.
    Peloquin, C. A.
    Pappa, K. A.
    Pakes, G. E.
    HIV MEDICINE, 2010, 11 (03) : 193 - 199
  • [7] Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
    Violari, Avy
    Lindsey, Jane C.
    Hughes, Michael D.
    Mujuru, Hilda A.
    Barlow-Mosha, Linda
    Kamthunzi, Portia
    Chi, Benjamin H.
    Cotton, Mark F.
    Moultrie, Harry
    Khadse, Sandhya
    Schimana, Werner
    Bobat, Raziya
    Purdue, Lynette
    Eshleman, Susan H.
    Abrams, Elaine J.
    Millar, Linda
    Petzold, Elizabeth
    Mofenson, Lynne M.
    Jean-Philippe, Patrick
    Palumbo, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (25): : 2380 - 2389
  • [8] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
    Dickinson, Laura
    Boffito, Marta
    Back, David
    Waters, Laura
    Else, Laura
    Davies, Geraint
    Khoo, Saye
    Pozniak, Anton
    Aarons, Leon
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1233 - 1243
  • [9] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    PLOS ONE, 2013, 8 (10):
  • [10] Interaction between Levothyroxine and Ritonavir-Boosted Amprenavir in Human Immunodeficiency Virus Infected Patients
    Ruellan, A.
    Veyroc, G.
    Lefebvre, M.
    Bonnet, B.
    Francois, C. Brunet
    Jolliet, P.
    DRUG SAFETY, 2011, 34 (10) : 934 - 934
12345